Home
>
US Stocks
>
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc
SRPT

Sarepta Therapeutics Inc (SRPT)

$63.154.49%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$67.18
Today Low/High$63.15 / $67.88
52 Week Low/High$65.17 / $103.34
P/E ratio-11.0
Market Cap-

Company Details

Sarepta Therapeutics Inc. is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Company's programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing.
OrganisationSarepta Therapeutics Inc
HeadquatersCambridge, Massachusetts, US
IndustryHealth Technology
CEODouglas Ingram

Discover more

Frequently Asked Questions

What is Sarepta Therapeutics Inc (SRPT) share price today?

Can Indians buy Sarepta Therapeutics Inc (SRPT) shares?

How can I buy Sarepta Therapeutics Inc (SRPT) shares from India?

Can Fractional shares of Sarepta Therapeutics Inc (SRPT) be purchased?

What are the documents required to start investing in Sarepta Therapeutics Inc (SRPT) stocks?